Skip to content

Xenobone

by Desu Medi̇kal Ürünler Ve Tibbi̇ Ci̇hazlar Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ Türkiye EUDAMED

Ref XBN-23W-6CC

EMDN N99

Regulatory status

as of 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDD NumberB-8680454759352BL Basic UDI-DIDate4 Nov 2025RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Expiring (legacy directive)
  • Not covered

European Union — CE/MDD Expiring (legacy directive)

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 23 Oct 2026

Device Name
Kolajen Bazlı Hayvansal Kaynaklı Kemik Grefti (Collagen Based Animal Derivered Bone Graft) - 2-3 mm, 6 cc Granül / Granule
Model / Reference
XBN-23W-6CC
Primary DI / UDI-DI
D-8680454759352BL
Basic UDI-DI
B-8680454759352BL
EMDN Code
N99 Nervous and medullary system devices - other
Device Class
Class III
Market of Registration
Türkiye

Manufacturer details

EUDAMED SRN
TR-MF-000031476

Other devices from Desu Medi̇kal Ürünler Ve Tibbi̇ Ci̇hazlar Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇

  • Desu

    Class III
  • Desu

    Class III
  • Desu

    Class III
  • Desu

    Class III
  • Desu

    Class III
  • Desu

    Class III

See all devices from Desu Medi̇kal Ürünler Ve Tibbi̇ Ci̇hazlar Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ →

Properties & raw data

Show properties, registry sources and raw records
  • Sterile
  • Implantable
  • Animal Tissues
Other properties (10)
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No

Sources (1)

  • EUDAMED 5dd656d1-158f-4311-a084-c9b018f858fd 61 fields · synced 23 Oct 2026